Rank | Gene Set | Z-score |
---|---|---|
1 | positive regulation of respiratory burst (GO:0060267) | 7.44035826 |
2 | antibacterial humoral response (GO:0019731) | 6.82154014 |
3 | antimicrobial humoral response (GO:0019730) | 6.55309308 |
4 | eosinophil chemotaxis (GO:0048245) | 6.48587310 |
5 | fructose metabolic process (GO:0006000) | 5.83329577 |
6 | eosinophil migration (GO:0072677) | 5.79124061 |
7 | angiotensin maturation (GO:0002003) | 5.61388785 |
8 | positive regulation of pseudopodium assembly (GO:0031274) | 5.60220313 |
9 | NADH metabolic process (GO:0006734) | 5.58747690 |
10 | glomerular filtration (GO:0003094) | 5.44684033 |
11 | complement activation, classical pathway (GO:0006958) | 5.40840264 |
12 | oligosaccharide catabolic process (GO:0009313) | 5.29079942 |
13 | regulation of guanylate cyclase activity (GO:0031282) | 5.26247664 |
14 | regulation of pseudopodium assembly (GO:0031272) | 5.04935246 |
15 | regulation of cellular extravasation (GO:0002691) | 4.99430633 |
16 | regulation of respiratory burst (GO:0060263) | 4.86585581 |
17 | renal filtration (GO:0097205) | 4.83763957 |
18 | chronic inflammatory response (GO:0002544) | 4.53488857 |
19 | complement activation (GO:0006956) | 4.52310441 |
20 | urea cycle (GO:0000050) | 4.47340577 |
21 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.46149559 |
22 | regulation of bile acid biosynthetic process (GO:0070857) | 4.44023228 |
23 | urea metabolic process (GO:0019627) | 4.43078911 |
24 | epoxygenase P450 pathway (GO:0019373) | 4.37127638 |
25 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.21285762 |
26 | alkaloid metabolic process (GO:0009820) | 4.18852088 |
27 | disruption of cells of other organism (GO:0044364) | 4.12068228 |
28 | killing of cells of other organism (GO:0031640) | 4.12068228 |
29 | nitrogen cycle metabolic process (GO:0071941) | 4.08330453 |
30 | intestinal absorption (GO:0050892) | 4.04193255 |
31 | GDP-mannose metabolic process (GO:0019673) | 4.00463319 |
32 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.97173589 |
33 | drug metabolic process (GO:0017144) | 3.97054807 |
34 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.95974644 |
35 | arginine metabolic process (GO:0006525) | 3.94995806 |
36 | regulation of triglyceride catabolic process (GO:0010896) | 3.85633150 |
37 | protein activation cascade (GO:0072376) | 3.77739143 |
38 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.76395557 |
39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.66253132 |
40 | drug catabolic process (GO:0042737) | 3.64527312 |
41 | vitamin transport (GO:0051180) | 3.63861340 |
42 | negative regulation of epidermal cell differentiation (GO:0045605) | 3.61653265 |
43 | bile acid and bile salt transport (GO:0015721) | 3.58027520 |
44 | phenylpropanoid metabolic process (GO:0009698) | 3.57934382 |
45 | defense response to fungus (GO:0050832) | 3.57138163 |
46 | diacylglycerol metabolic process (GO:0046339) | 3.55175978 |
47 | vitamin A metabolic process (GO:0006776) | 3.50322911 |
48 | low-density lipoprotein particle remodeling (GO:0034374) | 3.50279415 |
49 | cellular response to zinc ion (GO:0071294) | 3.49448642 |
50 | ethanol oxidation (GO:0006069) | 3.49406536 |
51 | cellular response to cadmium ion (GO:0071276) | 3.46694806 |
52 | regulation of protein glycosylation (GO:0060049) | 3.45123366 |
53 | hormone catabolic process (GO:0042447) | 3.44504496 |
54 | bile acid metabolic process (GO:0008206) | 3.39619865 |
55 | digestion (GO:0007586) | 3.35628922 |
56 | xenobiotic catabolic process (GO:0042178) | 3.34326375 |
57 | acute-phase response (GO:0006953) | 3.31309486 |
58 | humoral immune response (GO:0006959) | 3.30199384 |
59 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.27849429 |
60 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.27849429 |
61 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.26855935 |
62 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.24950355 |
63 | plasma lipoprotein particle assembly (GO:0034377) | 3.24843322 |
64 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.24125390 |
65 | regulation of cGMP biosynthetic process (GO:0030826) | 3.23471250 |
66 | plasma lipoprotein particle remodeling (GO:0034369) | 3.22707559 |
67 | protein-lipid complex remodeling (GO:0034368) | 3.22707559 |
68 | macromolecular complex remodeling (GO:0034367) | 3.22707559 |
69 | phospholipid efflux (GO:0033700) | 3.22209633 |
70 | glycolipid catabolic process (GO:0019377) | 3.14823700 |
71 | lipoprotein transport (GO:0042953) | 3.12275144 |
72 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.11959730 |
73 | L-ascorbic acid metabolic process (GO:0019852) | 3.10543688 |
74 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.09355161 |
75 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.06934512 |
76 | transcytosis (GO:0045056) | 3.02243656 |
77 | plasma lipoprotein particle organization (GO:0071827) | 3.00272277 |
78 | glycosphingolipid catabolic process (GO:0046479) | 2.91176193 |
79 | regulation of cholesterol esterification (GO:0010872) | 2.91061133 |
80 | lipoprotein metabolic process (GO:0042157) | 2.89232904 |
81 | uronic acid metabolic process (GO:0006063) | 2.89197428 |
82 | glucuronate metabolic process (GO:0019585) | 2.89197428 |
83 | ERK1 and ERK2 cascade (GO:0070371) | 2.88510884 |
84 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.88311485 |
85 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.88018563 |
86 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.87119965 |
87 | endocrine process (GO:0050886) | 2.87119965 |
88 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.87119965 |
89 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.86271687 |
90 | negative regulation of epidermis development (GO:0045683) | 2.86131230 |
91 | cellular glucuronidation (GO:0052695) | 2.84560741 |
92 | protein-lipid complex assembly (GO:0065005) | 2.81609680 |
93 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.79704679 |
94 | protein-lipid complex subunit organization (GO:0071825) | 2.78179444 |
95 | positive regulation of lipid catabolic process (GO:0050996) | 2.75528309 |
96 | sulfur amino acid catabolic process (GO:0000098) | 2.75237862 |
97 | ethanol metabolic process (GO:0006067) | 2.73976115 |
98 | regulation of protein activation cascade (GO:2000257) | 2.73839881 |
99 | peptide catabolic process (GO:0043171) | 2.73681487 |
100 | exogenous drug catabolic process (GO:0042738) | 2.72812721 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.74304699 |
2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.82967049 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.75529580 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.75469506 |
5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.60942505 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.60207949 |
7 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.25372224 |
8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.24612003 |
9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.86458375 |
10 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.83285731 |
11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.73671162 |
12 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.61599636 |
13 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.59238189 |
14 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.27827639 |
15 | GATA4_25053715_ChIP-Seq_YYC3_Human | 2.15814433 |
16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.14741697 |
17 | SOX2_20726797_ChIP-Seq_SW620_Human | 2.13163014 |
18 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.13042118 |
19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.07486445 |
20 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.06993570 |
21 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.95005379 |
22 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.88317536 |
23 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.87631506 |
24 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.79244502 |
25 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.76073234 |
26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.75386963 |
27 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67760319 |
28 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.62450350 |
29 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.59960385 |
30 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.59360571 |
31 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.53974662 |
32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.53777296 |
33 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.53348715 |
34 | SA1_27219007_Chip-Seq_Bcells_Human | 1.52070083 |
35 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.50851910 |
36 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.49481419 |
37 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.47720590 |
38 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.43049920 |
39 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.42803386 |
40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.38251289 |
41 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.35102233 |
42 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.33214124 |
43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.30785300 |
44 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.29196865 |
45 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.28055821 |
46 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.27708600 |
47 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.22188858 |
48 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.17459839 |
49 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.17171716 |
50 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13530097 |
51 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.13269282 |
52 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.12845352 |
53 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12601657 |
54 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12319768 |
55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12182263 |
56 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.11637974 |
57 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.10722116 |
58 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.10413292 |
59 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.09682977 |
60 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.07224974 |
61 | P300_27268052_Chip-Seq_Bcells_Human | 1.06251490 |
62 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.06096962 |
63 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.05538161 |
64 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03810206 |
65 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.03518753 |
66 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.01539977 |
67 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 1.01334535 |
68 | SOX2_21211035_ChIP-Seq_LN229_Human | 1.01282138 |
69 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.99795711 |
70 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.97620120 |
71 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97041958 |
72 | E2F1_20622854_ChIP-Seq_HELA_Human | 0.94748205 |
73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.94200104 |
74 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93047334 |
75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92565657 |
76 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.92443942 |
77 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.91770310 |
78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91729486 |
79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91567577 |
80 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91304827 |
81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.89837644 |
82 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89671293 |
83 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.88152375 |
84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.87230439 |
85 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.86241510 |
86 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.84810187 |
87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84567103 |
88 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.84464150 |
89 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.84278880 |
90 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.83065594 |
91 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82656276 |
92 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.82377705 |
93 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.81864580 |
94 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.80952375 |
95 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.80116428 |
96 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.78858954 |
97 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.78180603 |
98 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.77959967 |
99 | ERA_21632823_ChIP-Seq_H3396_Human | 0.77478601 |
100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77467909 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 7.06961063 |
2 | MP0002139_abnormal_hepatobiliary_system | 5.83778473 |
3 | MP0001666_abnormal_nutrient_absorption | 4.39593794 |
4 | MP0005085_abnormal_gallbladder_physiolo | 3.99167948 |
5 | MP0004019_abnormal_vitamin_homeostasis | 3.63813336 |
6 | MP0005365_abnormal_bile_salt | 3.52086031 |
7 | MP0009840_abnormal_foam_cell | 3.04282956 |
8 | MP0010155_abnormal_intestine_physiology | 2.94424324 |
9 | MP0002138_abnormal_hepatobiliary_system | 2.69165734 |
10 | MP0009379_abnormal_foot_pigmentation | 2.63211292 |
11 | MP0003806_abnormal_nucleotide_metabolis | 2.42791345 |
12 | MP0010329_abnormal_lipoprotein_level | 2.30779541 |
13 | MP0002876_abnormal_thyroid_physiology | 2.30578960 |
14 | MP0010234_abnormal_vibrissa_follicle | 2.22998986 |
15 | MP0003879_abnormal_hair_cell | 1.92599483 |
16 | MP0003183_abnormal_peptide_metabolism | 1.87969464 |
17 | MP0005332_abnormal_amino_acid | 1.87447718 |
18 | MP0003868_abnormal_feces_composition | 1.84245380 |
19 | MP0003724_increased_susceptibility_to | 1.82333708 |
20 | MP0005645_abnormal_hypothalamus_physiol | 1.80881920 |
21 | MP0005166_decreased_susceptibility_to | 1.78953709 |
22 | MP0001664_abnormal_digestion | 1.74503917 |
23 | MP0003252_abnormal_bile_duct | 1.69599669 |
24 | MP0003195_calcinosis | 1.68185408 |
25 | MP0008875_abnormal_xenobiotic_pharmacok | 1.65543929 |
26 | MP0000013_abnormal_adipose_tissue | 1.65174891 |
27 | MP0003866_abnormal_defecation | 1.54495014 |
28 | MP0005387_immune_system_phenotype | 1.53088998 |
29 | MP0001790_abnormal_immune_system | 1.53088998 |
30 | MP0000490_abnormal_crypts_of | 1.48530272 |
31 | MP0009643_abnormal_urine_homeostasis | 1.47004914 |
32 | MP0009785_altered_susceptibility_to | 1.44762261 |
33 | MP0001663_abnormal_digestive_system | 1.43808579 |
34 | MP0005058_abnormal_lysosome_morphology | 1.41835691 |
35 | MP0002118_abnormal_lipid_homeostasis | 1.40096729 |
36 | MP0001845_abnormal_inflammatory_respons | 1.38482226 |
37 | MP0006082_CNS_inflammation | 1.33302696 |
38 | MP0003303_peritoneal_inflammation | 1.30508466 |
39 | MP0003436_decreased_susceptibility_to | 1.28223725 |
40 | MP0003718_maternal_effect | 1.27600565 |
41 | MP0001764_abnormal_homeostasis | 1.25205287 |
42 | MP0000477_abnormal_intestine_morphology | 1.24409898 |
43 | MP0009764_decreased_sensitivity_to | 1.24376848 |
44 | MP0005025_abnormal_response_to | 1.23716313 |
45 | MP0010352_gastrointestinal_tract_polyps | 1.20485417 |
46 | MP0005409_darkened_coat_color | 1.17389022 |
47 | MP0002148_abnormal_hypersensitivity_rea | 1.17019362 |
48 | MP0005381_digestive/alimentary_phenotyp | 1.16180616 |
49 | MP0001873_stomach_inflammation | 1.14373462 |
50 | MP0001835_abnormal_antigen_presentation | 1.10937672 |
51 | MP0000462_abnormal_digestive_system | 1.10015432 |
52 | MP0004858_abnormal_nervous_system | 1.08703990 |
53 | MP0000609_abnormal_liver_physiology | 1.07546087 |
54 | MP0004264_abnormal_extraembryonic_tissu | 1.07379191 |
55 | MP0003075_altered_response_to | 1.03897052 |
56 | MP0003191_abnormal_cellular_cholesterol | 1.03748717 |
57 | MP0008469_abnormal_protein_level | 1.03431137 |
58 | MP0005636_abnormal_mineral_homeostasis | 1.02195124 |
59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01872131 |
60 | MP0003300_gastrointestinal_ulcer | 0.98401415 |
61 | MP0001765_abnormal_ion_homeostasis | 0.97723208 |
62 | MP0001533_abnormal_skeleton_physiology | 0.97332687 |
63 | MP0005535_abnormal_body_temperature | 0.96534595 |
64 | MP0001501_abnormal_sleep_pattern | 0.95558432 |
65 | MP0000538_abnormal_urinary_bladder | 0.94541830 |
66 | MP0004147_increased_porphyrin_level | 0.91634401 |
67 | MP0008872_abnormal_physiological_respon | 0.91632187 |
68 | MP0001756_abnormal_urination | 0.91005977 |
69 | MP0002166_altered_tumor_susceptibility | 0.90732303 |
70 | MP0003638_abnormal_response/metabolism_ | 0.88799993 |
71 | MP0005448_abnormal_energy_balance | 0.88677632 |
72 | MP0000604_amyloidosis | 0.88252316 |
73 | MP0002136_abnormal_kidney_physiology | 0.88236342 |
74 | MP0010386_abnormal_urinary_bladder | 0.86856688 |
75 | MP0005451_abnormal_body_composition | 0.83366409 |
76 | MP0002254_reproductive_system_inflammat | 0.82329762 |
77 | MP0003959_abnormal_lean_body | 0.80257490 |
78 | MP0005165_increased_susceptibility_to | 0.79524271 |
79 | MP0002277_abnormal_respiratory_mucosa | 0.77865271 |
80 | MP0005319_abnormal_enzyme/_coenzyme | 0.77816349 |
81 | MP0005000_abnormal_immune_tolerance | 0.76463177 |
82 | MP0001800_abnormal_humoral_immune | 0.74208827 |
83 | MP0003878_abnormal_ear_physiology | 0.73630733 |
84 | MP0005377_hearing/vestibular/ear_phenot | 0.73630733 |
85 | MP0001485_abnormal_pinna_reflex | 0.73437409 |
86 | MP0002796_impaired_skin_barrier | 0.72999201 |
87 | MP0009333_abnormal_splenocyte_physiolog | 0.71070688 |
88 | MP0002971_abnormal_brown_adipose | 0.69904680 |
89 | MP0009642_abnormal_blood_homeostasis | 0.69213077 |
90 | MP0002078_abnormal_glucose_homeostasis | 0.69168210 |
91 | MP0002419_abnormal_innate_immunity | 0.67650943 |
92 | MP0005671_abnormal_response_to | 0.66554664 |
93 | MP0000685_abnormal_immune_system | 0.65548737 |
94 | MP0000678_abnormal_parathyroid_gland | 0.64063180 |
95 | MP0005408_hypopigmentation | 0.63260931 |
96 | MP0002723_abnormal_immune_serum | 0.61776391 |
97 | MP0002006_tumorigenesis | 0.61634743 |
98 | MP0005395_other_phenotype | 0.60042836 |
99 | MP0001819_abnormal_immune_cell | 0.59254300 |
100 | MP0000249_abnormal_blood_vessel | 0.58258851 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 7.30678181 |
2 | Systemic lupus erythematosus (HP:0002725) | 6.80028907 |
3 | Malnutrition (HP:0004395) | 5.63906396 |
4 | Hypobetalipoproteinemia (HP:0003563) | 4.46531376 |
5 | Complement deficiency (HP:0004431) | 4.20778238 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.20260105 |
7 | Abnormality of proline metabolism (HP:0010907) | 4.05354244 |
8 | Hydroxyprolinuria (HP:0003080) | 4.05354244 |
9 | Glomerulonephritis (HP:0000099) | 4.00273632 |
10 | Glycosuria (HP:0003076) | 3.90782601 |
11 | Abnormality of urine glucose concentration (HP:0011016) | 3.90782601 |
12 | Abnormality of complement system (HP:0005339) | 3.90747557 |
13 | Proximal tubulopathy (HP:0000114) | 3.86379248 |
14 | Xanthomatosis (HP:0000991) | 3.74869140 |
15 | Nausea (HP:0002018) | 3.62519653 |
16 | Congenital sensorineural hearing impairment (HP:0008527) | 3.51902111 |
17 | Nephritis (HP:0000123) | 3.34000850 |
18 | Fat malabsorption (HP:0002630) | 3.27423427 |
19 | Prolonged partial thromboplastin time (HP:0003645) | 3.24886372 |
20 | Abnormality of vitamin B metabolism (HP:0004340) | 3.19658709 |
21 | Ileus (HP:0002595) | 3.15382625 |
22 | Chronic diarrhea (HP:0002028) | 3.11634149 |
23 | Deep venous thrombosis (HP:0002625) | 3.10813825 |
24 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.08706737 |
25 | Hyperphosphaturia (HP:0003109) | 3.04221801 |
26 | Hyperuricemia (HP:0002149) | 3.03561669 |
27 | Increased purine levels (HP:0004368) | 3.03561669 |
28 | Alkalosis (HP:0001948) | 3.01897148 |
29 | Widely patent fontanelles and sutures (HP:0004492) | 2.93410434 |
30 | Confusion (HP:0001289) | 2.88530784 |
31 | Abnormality of vitamin metabolism (HP:0100508) | 2.76178633 |
32 | Abnormal urine phosphate concentration (HP:0012599) | 2.76101112 |
33 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.68551091 |
34 | Hyperammonemia (HP:0001987) | 2.67463045 |
35 | Eczematoid dermatitis (HP:0000976) | 2.65426876 |
36 | Pancreatitis (HP:0001733) | 2.63616385 |
37 | Abnormality of purine metabolism (HP:0004352) | 2.62069842 |
38 | Abnormality of nucleobase metabolism (HP:0010932) | 2.60479693 |
39 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.59804687 |
40 | Dicarboxylic aciduria (HP:0003215) | 2.59804687 |
41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.57742690 |
42 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.57010277 |
43 | Steatorrhea (HP:0002570) | 2.55712034 |
44 | Hypophosphatemia (HP:0002148) | 2.51843342 |
45 | Metabolic alkalosis (HP:0200114) | 2.50036344 |
46 | Hypolipoproteinemia (HP:0010981) | 2.48317211 |
47 | Decreased circulating renin level (HP:0003351) | 2.45770637 |
48 | Tongue fasciculations (HP:0001308) | 2.43735118 |
49 | Stridor (HP:0010307) | 2.42022465 |
50 | Metabolic acidosis (HP:0001942) | 2.36943276 |
51 | Abnormality of macrophages (HP:0004311) | 2.35125810 |
52 | Lethargy (HP:0001254) | 2.31676310 |
53 | Vacuolated lymphocytes (HP:0001922) | 2.29523302 |
54 | Generalized aminoaciduria (HP:0002909) | 2.27620038 |
55 | Delayed CNS myelination (HP:0002188) | 2.25345046 |
56 | Myopathic facies (HP:0002058) | 2.22734210 |
57 | Amyloidosis (HP:0011034) | 2.20907939 |
58 | Irritability (HP:0000737) | 2.20821436 |
59 | Muscle fibrillation (HP:0010546) | 2.20740351 |
60 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.20399146 |
61 | Wide cranial sutures (HP:0010537) | 2.19779856 |
62 | Gout (HP:0001997) | 2.17831310 |
63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.15622640 |
64 | Hypotension (HP:0002615) | 2.13431393 |
65 | Nephrolithiasis (HP:0000787) | 2.11509634 |
66 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.10891031 |
67 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.10716041 |
68 | Abnormality of glycine metabolism (HP:0010895) | 2.10716041 |
69 | Joint hemorrhage (HP:0005261) | 2.09684189 |
70 | Acanthocytosis (HP:0001927) | 2.08300600 |
71 | Intrahepatic cholestasis (HP:0001406) | 2.01527873 |
72 | Polyphagia (HP:0002591) | 2.01134045 |
73 | Gastrointestinal infarctions (HP:0005244) | 1.98824676 |
74 | Pigmentary retinal degeneration (HP:0001146) | 1.96581067 |
75 | Hyperglycinuria (HP:0003108) | 1.94907608 |
76 | Vomiting (HP:0002013) | 1.94841110 |
77 | Potter facies (HP:0002009) | 1.94552938 |
78 | Facial shape deformation (HP:0011334) | 1.94552938 |
79 | Diaphragmatic weakness (HP:0009113) | 1.92751130 |
80 | Cerebral palsy (HP:0100021) | 1.92159378 |
81 | Purpura (HP:0000979) | 1.92099536 |
82 | Hypothermia (HP:0002045) | 1.91206148 |
83 | Thin bony cortex (HP:0002753) | 1.91167362 |
84 | Ketosis (HP:0001946) | 1.90161890 |
85 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.90077750 |
86 | Orchitis (HP:0100796) | 1.89167153 |
87 | Facial diplegia (HP:0001349) | 1.88865383 |
88 | Renal tubular dysfunction (HP:0000124) | 1.88258094 |
89 | Growth hormone excess (HP:0000845) | 1.87234501 |
90 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.85098474 |
91 | Renal tubular acidosis (HP:0001947) | 1.84779056 |
92 | Dysostosis multiplex (HP:0000943) | 1.84724172 |
93 | Progressive neurologic deterioration (HP:0002344) | 1.83722853 |
94 | Abdominal distention (HP:0003270) | 1.83208761 |
95 | Recurrent pneumonia (HP:0006532) | 1.82455256 |
96 | Bulbar palsy (HP:0001283) | 1.82402158 |
97 | Abnormality of magnesium homeostasis (HP:0004921) | 1.82106085 |
98 | Neonatal onset (HP:0003623) | 1.81271851 |
99 | Petechiae (HP:0000967) | 1.80962324 |
100 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79976435 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 6.49827200 |
2 | ERN1 | 4.98420134 |
3 | LMTK2 | 3.61070945 |
4 | PRKG2 | 3.26630432 |
5 | PTK6 | 2.35723546 |
6 | TYK2 | 2.21947056 |
7 | EPHB2 | 2.12606900 |
8 | EPHA2 | 2.11694928 |
9 | MAP3K12 | 2.11360649 |
10 | VRK2 | 2.07368538 |
11 | FGFR4 | 2.05138431 |
12 | TESK2 | 1.99401038 |
13 | RIPK1 | 1.84885448 |
14 | GRK6 | 1.79105920 |
15 | MAP2K2 | 1.78441539 |
16 | MAP2K6 | 1.68574115 |
17 | MYLK | 1.66525444 |
18 | TBK1 | 1.61628055 |
19 | ADRBK2 | 1.60660289 |
20 | TESK1 | 1.59466408 |
21 | MAP3K11 | 1.58075755 |
22 | MAP4K1 | 1.58056665 |
23 | TAOK1 | 1.50696202 |
24 | GRK1 | 1.42366406 |
25 | ABL2 | 1.34967569 |
26 | MST1R | 1.33183638 |
27 | STK24 | 1.31066014 |
28 | EPHA3 | 1.26335609 |
29 | MAP3K1 | 1.26330225 |
30 | MATK | 1.24934034 |
31 | IKBKE | 1.20522642 |
32 | OXSR1 | 1.10711570 |
33 | ZAP70 | 1.09091141 |
34 | MST4 | 1.02983055 |
35 | DAPK2 | 1.00909095 |
36 | EPHB1 | 0.99470737 |
37 | RIPK4 | 0.99146540 |
38 | PRKACG | 0.97787704 |
39 | PIK3CA | 0.96347740 |
40 | BRAF | 0.94684493 |
41 | PKN2 | 0.91366702 |
42 | CSK | 0.90945832 |
43 | DDR2 | 0.90033426 |
44 | BMX | 0.89904035 |
45 | ARAF | 0.89438912 |
46 | JAK2 | 0.88632790 |
47 | IRAK3 | 0.88597310 |
48 | PDPK1 | 0.87611559 |
49 | FRK | 0.83749923 |
50 | PIM2 | 0.82195917 |
51 | FGFR3 | 0.82172444 |
52 | NLK | 0.79951241 |
53 | MAP3K10 | 0.79543879 |
54 | IKBKB | 0.78154429 |
55 | PRKCA | 0.76644864 |
56 | TLK1 | 0.76292397 |
57 | FER | 0.72611585 |
58 | BLK | 0.71376889 |
59 | TXK | 0.70627294 |
60 | PRKCZ | 0.70011341 |
61 | ERBB2 | 0.66125385 |
62 | STK39 | 0.65058986 |
63 | MAPK11 | 0.63897931 |
64 | MAP3K2 | 0.62412423 |
65 | CAMK2D | 0.61451697 |
66 | CLK1 | 0.60851232 |
67 | TAOK2 | 0.59968752 |
68 | PRKCI | 0.59639945 |
69 | KIT | 0.58900883 |
70 | PRKCQ | 0.57248079 |
71 | MARK3 | 0.56852277 |
72 | DAPK3 | 0.56837228 |
73 | CDC42BPA | 0.56735208 |
74 | PDK1 | 0.53801679 |
75 | JAK3 | 0.52765093 |
76 | CDK19 | 0.52488953 |
77 | LYN | 0.51586532 |
78 | TNIK | 0.49899344 |
79 | JAK1 | 0.48517583 |
80 | SYK | 0.45871404 |
81 | PRKAA2 | 0.43274097 |
82 | RPS6KC1 | 0.41144078 |
83 | RPS6KL1 | 0.41144078 |
84 | PRKG1 | 0.40924629 |
85 | ADRBK1 | 0.40917272 |
86 | RPS6KA6 | 0.40408803 |
87 | GSK3A | 0.39843879 |
88 | BCKDK | 0.36981890 |
89 | PRKACA | 0.36762485 |
90 | DAPK1 | 0.36337438 |
91 | PRKCD | 0.36326849 |
92 | IRAK1 | 0.33880604 |
93 | NME1 | 0.33685854 |
94 | SRC | 0.31921571 |
95 | PRKCE | 0.30843609 |
96 | EPHA4 | 0.30832524 |
97 | MAP3K3 | 0.30640841 |
98 | KDR | 0.29637923 |
99 | IGF1R | 0.29246813 |
100 | LCK | 0.29029765 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.42230535 |
2 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.78351854 |
3 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.38264262 |
4 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.06505259 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.73692848 |
6 | Asthma_Homo sapiens_hsa05310 | 2.69497470 |
7 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.45157023 |
8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.26007606 |
9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.15662904 |
10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.15031979 |
11 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13815734 |
12 | Histidine metabolism_Homo sapiens_hsa00340 | 2.04059138 |
13 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.02463208 |
14 | Mineral absorption_Homo sapiens_hsa04978 | 1.98383064 |
15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.94892366 |
16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.91068488 |
17 | Retinol metabolism_Homo sapiens_hsa00830 | 1.89784804 |
18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.85570150 |
19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.78110894 |
20 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.71377607 |
21 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.70127237 |
22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.68026379 |
23 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64523462 |
24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.61029548 |
25 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.60384276 |
26 | Allograft rejection_Homo sapiens_hsa05330 | 1.57005565 |
27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.53409508 |
28 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.52782191 |
29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.52626475 |
30 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.51061619 |
31 | Bile secretion_Homo sapiens_hsa04976 | 1.50587079 |
32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.44730162 |
33 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.44311924 |
34 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.43666670 |
35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.36084360 |
36 | Sulfur relay system_Homo sapiens_hsa04122 | 1.36032928 |
37 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.33817850 |
38 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31035415 |
39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30647157 |
40 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.24120911 |
41 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.21391579 |
42 | Peroxisome_Homo sapiens_hsa04146 | 1.16154280 |
43 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14605049 |
44 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.13119936 |
45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.08192002 |
46 | Other glycan degradation_Homo sapiens_hsa00511 | 0.95674297 |
47 | Galactose metabolism_Homo sapiens_hsa00052 | 0.94303349 |
48 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.90748570 |
49 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.89431788 |
50 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.86654048 |
51 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.84372221 |
52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.83976618 |
53 | Pertussis_Homo sapiens_hsa05133 | 0.82199106 |
54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.78453495 |
55 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.78110501 |
56 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.75457642 |
57 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71853516 |
58 | Leishmaniasis_Homo sapiens_hsa05140 | 0.71585249 |
59 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70072856 |
60 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69577535 |
61 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.69161056 |
62 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.63193488 |
63 | Prion diseases_Homo sapiens_hsa05020 | 0.62477855 |
64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.61892735 |
65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.61427035 |
66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58615895 |
67 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56204340 |
68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54550838 |
69 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54408265 |
70 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.49869419 |
71 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.43661155 |
72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.42030939 |
73 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39998544 |
74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38818529 |
75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.38619059 |
76 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.38407923 |
77 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.37128667 |
78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36593404 |
79 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35505281 |
80 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.35075887 |
81 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33645167 |
82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.32856747 |
83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.29781136 |
84 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.29117519 |
85 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27583530 |
86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.26934950 |
87 | Carbon metabolism_Homo sapiens_hsa01200 | 0.26461199 |
88 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.25600348 |
89 | Lysosome_Homo sapiens_hsa04142 | 0.25161412 |
90 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24599184 |
91 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.22056457 |
92 | Tuberculosis_Homo sapiens_hsa05152 | 0.21725233 |
93 | Phagosome_Homo sapiens_hsa04145 | 0.20827074 |
94 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.16957517 |
95 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.16452389 |
96 | Parkinsons disease_Homo sapiens_hsa05012 | 0.16277954 |
97 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.13216687 |
98 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.12215262 |
99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.11166145 |
100 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.10845656 |